|
Pre-market: Weak global cues may drag markets at start
|
Thursday, February 7, 2013 |
| 
| February 08, 2013 | 8.30 AM | Weak global cues may drag markets at start The Indian markets are expected to start trading on a negative note led by weak global cues. SGX Nifty is trading 4.00 points lower. | | | | | | Headlines for the day | - Ambuja Q4 net dips 30% to Rs211 crore
- Aurobindo Pharma posts net profit of Rs92 cr in Q3
- Power Grid to raise Rs3,000 cr via bond issue in FY13
| Events for the day | Results: Bharat Forge, Hindalco Industries, M&M, Max India, Tata Chemicals, Sun Pharma, Canara Bank, Emami, Cadila Health, GMR Infra, GSPL, BGR Energy. | | | STOCK TO WATCH |  | | | | | | | FOREX |  | | | | | | | | | | | | INDIAN INDICES |  | | | | | | Indices | Support | Resistance | | | | | The Indian equities may begin last trading session of the week on a negative note tracking weak global cues. SGX Nifty is also trading 4.00 points higher. On Thursday (February 07, 2013), the Sensex closed at 19580.32, down by 59.40 points while the Nifty settled at 5938.80, falling by 20.40 points. | | | | | FII/MF ACTIVITIES |  | | | As on 06-02-2013 | FII (Rs cr) | MF* (Rs cr) | | Gross purchase | 4224.80 | 343.20 | | Gross sale | 2882.10 | 824.50 | | Net investment | 1342.70 | (481.30) | | | | Daily trend of FII/MF investment in equities The FIIs have been the net buyers Indian stocks to the tune of Rs1342.70 crore on February 06, 2013. The domestic investors sold Indian shares worth a net of Rs481.30 crore on February 06, 2013.The data is as per the SEBI website. | | | | GLOBAL INDICES |  | | | | | | | Asian shares were capped on Friday after European Central Bank President Mario Draghi noted risks still facing the euro zone economy, turning investor sentiment more cautious ahead of Chinese trade data for January due out during the session. US stocks declined on Thursday, taking a step back from their recent advance, prompted by comments by the ECB president on the euro and Europe's outlook. European shares turned negative in choppy trading on Thursday, tracking falls on the U.S. equity markets, while a decline in French drugmaker Sanofi also weighed on the region's bourses. | | | | | | Commodity cues Crude Oil reached its highest level since September on Thursday after the head of the European Central Bank chief said inflationary pressures were likely to diminish and due to renewed tensions in the Middle East. | COMMODITIES |  | | | Commodity (MCX) | Price (Rs) | % Chg | | | | | | | | | | | | Manage your newsletter subscriptions | | | | | | | | |
| | | To know more about our products and services, click here. | | | | Sharekhan Ltd. Regd Add: 10th Floor, Beta Building, Lodha iThink Techno Campus, Off. JVLR, Opp. Kanjurmarg Railway Station, Kanjurmarg (East), Mumbai - 400 042, Maharashtra. Tel: 022 - 61150000. BSE Cash-INB011073351; F&O-INF011073351; NSE - INB/INF231073330; CD - INE231073330; MCX Stock Exchange : CD - INE261073330 DP: NSDL-IN-DP-NSDL-233-2003; CDSL-IN-DP-CDSL-271-2004; PMS INP000000662; Mutual Fund: ARN 20669. | | | | | | "This document has been prepared by Sharekhan Ltd. This Document is subject to changes without prior notice and is intended only for the person or entity to which it is addressed to and may contain confidential and/or privileged material and is not for any type of circulation. Any review, retransmission, or any other use is prohibited. Kindly note that this document does not constitute an offer or solicitation for the purchase or sale of any financial instrument or as an official confirmation of any transaction. Though disseminated to all the customers simultaneously, not all customers may receive this report at the same time. SHAREKHAN will not treat recipients as customers by virtue of their receiving this report. The information contained herein is from publicly available data or other sources believed to be reliable. While we would endeavour to update the information herein on reasonable basis, SHAREKHAN, its subsidiaries and associated companies, their directors and employees ("SHAREKHAN and affiliates") are under no obligation to update or keep the information current. Also, there may be regulatory, compliance, or other reasons that may prevent SHAREKHAN and affiliates from doing so. We do not represent that information contained herein is accurate or complete and it should not be relied upon as such. This document is prepared for assistance only and is not intended to be and must not alone betaken as the basis for an investment decision. The user assumes the entire risk of any use made of this information. Each recipient of this document should make such investigations as it deems necessary to arrive at an independent evaluation of an investment in the securities of companies referred to in this document (including the merits and risks involved), and should consult its own advisors to determine the merits and risks of such an investment. The investment discussed or views expressed may not be suitable for all investors. We do not undertake to advise you as to any change of our views. Affiliates of Sharekhan may have issued other reports that are inconsistent with and reach different conclusion from the information presented in this report. This report is not directed or intended for distribution to, or use by, any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject SHAREKHAN and affiliates to any registration or licensing requirement within such jurisdiction. The securities described herein may or may not be eligible for sale in all jurisdictions or to certain category of investors. Persons in whose possession this document may come are required to inform themselves of and to observe such restriction. SHAREKHAN & affiliates may have used the information set forth herein before publication and may have positions in, may from time to time purchase or sell or may be materially interested in any of the securities mentioned or related securities. SHAREKHAN may from time to time solicit from, or perform investment banking, or other services for, any company mentioned herein. Without limiting any of the foregoing, in no event shall SHAREKHAN, any of its affiliates or any third party involved in, or related to, computing or compiling the information have any liability for any damages of any kind. Any comments or statements made herein are those of the analyst and do not necessarily reflect those of SHAREKHAN." | To unsubscribe write to mailto:retail@sski.co.in?subject=Unsubscribe
| | | |
posted by Anonymous @ 9:55 PM  |
|
1 Comments: |
-
Whole sale Price Index (WPI) inflation for January 2013 positively moderated for the fourth straight month and slipped below 7.0% for the first time since December 2009, marking a three-year low. Headline WPI inflation stood at 6.6% yoy in January 2013 as compared to 7.2% yoy in the previous month as well as in January 2012. On a 3MMA basis, headline WPI inflation eased to 7.0% yoy as compared to 7.3% yoy in November 2012. Core inflation receded for the fifth straight month to 4.1% yoy as compared to 4.2% yoy in the previous month and 7.0% yoy in the corresponding period of the previous year.
Regards BIGPROFITBUZZ TEAM
|
|
<< Home |
|
|
|
|
Whole sale Price Index (WPI) inflation for January 2013 positively moderated for the fourth straight month and slipped below 7.0% for the first time since December 2009, marking a three-year low. Headline WPI inflation stood at 6.6% yoy in January 2013 as compared to 7.2% yoy in the previous month as well as in January 2012. On a 3MMA basis, headline WPI inflation eased to 7.0% yoy as compared to 7.3% yoy in November 2012. Core inflation receded for the fifth straight month to 4.1% yoy as compared to 4.2% yoy in the previous month and 7.0% yoy in the corresponding period of the previous year.
Regards
BIGPROFITBUZZ TEAM